NATURES SUNSHINE PRODUCTS INC
No SEC Form 4 filings for $NATR in the last 30 days.
Nature’s Sunshine (NASDAQ: NATR) shares fell 17.7% after the company reported Q2 2026 results that missed Wall Street. Revenue was $117 million, 5.4% below estimates, and adjusted EPS was $0.21, 22.2% below expectations. It also cut full-year revenue guidance to $495 million at the midpoint, down 2.5% from prior guidance.
Nature’s Sunshine (NASDAQ: NATR) reported Q2 CY2026 sales of $117 million, up 1.9% year on year, missing Wall Street expectations. Full-year revenue guidance was $495 million at the midpoint, about 2.5% below estimates. Non-GAAP EPS was $0.21, 22.2% below consensus. The stock fell 14.3% to $17.48.
NATURES SUNSHINE PRODUCTS INC (NATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 3 natrq22026earningsrelease.htm EX-99.1 Document Nature's Sunshine Reports Second Quarter 2026 Results Net Sales up 2% to $117.0 million, Gross Profit Margin up 194 Basis Points to 73.7% LEHI, Utah – August 6, 2026 – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Natur
Over the past 7 days, alphai's AI scored 4 news stories mentioning NATR (NATURES SUNSHINE PRODUCTS INC). Coverage has skewed bearish: 0 bullish, 2 neutral, and 2 bearish.
Recent NATR coverage spans earnings, financial news and insider activity.
The earnings miss plus a modest but negative revenue-guidance cut is likely to keep near-term sentiment weak and pressure estimates.
The miss plus below-consensus full-year revenue guidance and weaker non-GAAP EPS likely pressure near-term estimates and sentiment.
Guidance reset plus margin improvement in Q2 creates a mixed setup: near-term demand headwinds (FX and China) offset by gross margin expansion and digital sales momentum.
This is a pre-earnings positioning piece for NATR, emphasizing consensus revenue growth, prior-quarter beats, and the stock’s underperformance versus peers.
Routine insider selling disclosure; may slightly affect sentiment but is unlikely to change fundamentals absent additional company-specific news.
alphai scores every news story that mentions NATR with an AI model for sentiment and relevance, and aggregates insider trades from NATURES SUNSHINE PRODUCTS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Nature’s Sunshine (NASDAQ: NATR) shares fell 17.7% after the company reported Q2 2026 results that missed Wall Street. Revenue was $117 million, 5.4% below estimates, and adjusted EPS was $0.21, 22.2% below expectations. It also cut full-year revenue guidance to $495 million at the midpoint, down 2.5% from prior guidance.
4 min readNature’s Sunshine (NASDAQ: NATR) reported Q2 CY2026 sales of $117 million, up 1.9% year on year, missing Wall Street expectations. Full-year revenue guidance was $495 million at the midpoint, about 2.5% below estimates. Non-GAAP EPS was $0.21, 22.2% below consensus. The stock fell 14.3% to $17.48.
6 min readNATURES SUNSHINE PRODUCTS INC (NATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 3 natrq22026earningsrelease.htm EX-99.1 Document Nature's Sunshine Reports Second Quarter 2026 Results Net Sales up 2% to $117.0 million, Gross Profit Margin up 194 Basis Points to 73.7% LEHI, Utah – August 6, 2026 – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Natur
6 min readNature’s Sunshine (NATR) will report Q2 earnings Thursday after the bell. The company previously reported Q1 revenue of $122.9M, up 8.5% YoY, and beat analysts on EPS and EBITDA. For Q2, analysts expect revenue up 7.8% YoY. The article cites an average analyst price target of $34.50 vs a $20.45 share price.
3 min readYates Bryant J (EVP & President, Europe) sold 11,968 shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $19.90 ($0.24M total) on 2026-06-05.
2 min readNorman Daniel C (EVP & President, Asia) sold 9,713 shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $20.64 ($0.20M total) on 2026-06-01.
1 min readNature's Sunshine Products Inc (NATR) generates most of its revenue from the General Health segment, contributing 41.3% or $47.38M of total sales, followed by Digestive and Cardiovascular segments. The company demonstrates strong profitability with a gross margin of 72.52%, an operating margin of 4.30%, and a net margin of 3.65%, alongside a 12.32% Return on Equity. NATR, with a market capitalization of $462.55M, outperforms competitors like NAGE in gross margin but trails USNA.
4 min readWall Street analysts have raised price targets on Five Below (FIVE), Ulta Beauty (ULTA), and Nature's Sunshine Products (NATR) ahead of their upcoming earnings reports, signaling confidence in their business momentum and execution. Barclays increased Five Below's target to $211, Canaccord Genuity lifted Ulta Beauty's to $799, and Nature's Sunshine's target was raised to $29. The revisions reflect analysts' positioning before the results, with varying degrees of implied upside for each company based on their current stock prices.
3 min readNature's Sunshine Products, Inc. (NASDAQ:NATR) currently appears to be trading at a significant discount, with its share price of US$21.51 signalling it might be 32% undervalued compared to its estimated fair value of US$31.76. This valuation is based on a 2-stage Discounted Cash Flow (DCF) model and suggests that the company's future cash flows make it an attractive investment, especially given its peers are trading at a 77% premium on average. Investors are encouraged to consider the assumptions behind DCF models and explore other fundamental factors like management and potential risks.
4 min readAs of Nov. 12, 2025, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...
4 min read
